Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Contract Research Organization Services (CROs) - Global Strategic Business Report: Capitalize on a $149.1B Market by 2030 as IQVIA, ICON, Parexel and WuXi AppTec Accelerate AI-Led Trials

globenewswire.com

Contract Research Organization Services (CROs) - Global Strategic Business Report: Capitalize on a $149.1B Market by 2030 as IQVIA, ICON, Parexel and WuXi AppTec Accelerate AI-Led Trials Dublin, Oct. 27, 2026 (GLOBE NEWSWIRE) -- "Contract Research Organization Services (CROs) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global Contract Research Organization Services (CROs) market, valued at US$81.4 billion in 2024, is projected to reach US$149.1 billion by 2030. The market is expected to expand at a compound annual growth rate of 10.6% during the 2024-2030 forecast period, supported by increased research outsourcing, growing drug development complexity, technological innovation, and the globalization of clinical trials.

The comprehensive Contract Research Organization Services market report examines major industry trends, growth drivers, competitive conditions, market forecasts, and regional opportunities. It also incorporates recent global tariff and trade developments, assessing their effects on supply chains, sourcing strategies, operating costs, clinical research activity, and the geographic distribution of CRO services.

Contract Research Organization Services Market Trends and Growth Drivers

Pharmaceutical, biotechnology, and medical device companies continue to increase their reliance on CROs for clinical research, early-phase development, laboratory services, regulatory support, data management, and commercialization-related activities. Outsourcing enables sponsors to access specialized scientific expertise, advanced research infrastructure, multinational clinical site networks, and regional regulatory capabilities while improving operational flexibility and accelerating development timelines.

Rising drug development costs and increasingly complex study protocols are strengthening demand for experienced CRO partners. Growth in personalized medicine, biologics, oncology therapies, central nervous system treatments, and other advanced therapeutic categories is also creating opportunities for providers with specialized scientific, clinical, and regulatory expertise.

Technology is reshaping the CRO industry through artificial intelligence, machine learning, advanced data analytics, electronic data capture, remote monitoring, telemedicine, and connected health devices. These technologies support clinical trial design, patient identification, recruitment, site selection, data analysis, and real-time study oversight. Decentralized and hybrid clinical trial models are also broadening patient access and improving engagement across remote and underserved populations.

Although CRO partnerships can provide cost efficiencies and expanded capabilities, sponsors must address communication, coordination, data security, regulatory compliance, and research quality. Strong governance frameworks, clearly defined contracts, transparent performance metrics, and effective oversight remain essential to successful outsourcing relationships.

Domain Expert Insights

The report tracks the expanding strategic role of CROs across the global pharmaceutical and biotechnology value chain. Industry growth is being reinforced by the need for scalable research capacity, therapeutic specialization, international trial management, and faster access to high-quality clinical data. CROs that combine global operating reach with localized regulatory knowledge are well positioned to support increasingly complex multinational studies.

The report tracks advances in AI-enabled analytics, decentralized clinical trials, remote patient monitoring, and digital data management as important competitive differentiators. It also evaluates how tariff negotiations, economic uncertainty, supply chain disruption, and changing globalization patterns may influence research investment, vendor selection, laboratory sourcing, and regional expansion through 2030.

Market Segmentation and Geographic Coverage

Key Contract Research Organization Services Market Findings

Report Benefits

Competitive Landscape

The report profiles 307 companies operating within the global CRO services market. Featured organizations include:

Trade, Tariff, and Economic Analysis

This edition evaluates tariff negotiations involving more than 180 countries and assesses their implications for supply chain stability, procurement, geographic realignment, and CRO operating strategies. Revised global and regional forecasts through 2030 account for tariff effects, economic uncertainty, competitive developments, population trends, urbanization, and evolving investment conditions.

The report also examines product and process innovation, emerging research technologies, regional market prospects, and the competitive positioning of leading global providers. Commentary from economists, trade specialists, and domain experts provides additional context for organizations evaluating partnerships, market entry strategies, investment priorities, and long-term opportunities in the global Contract Research Organization Services market.

Key Attributes:

For more information about this report visit https://www.researchandmarkets.com/r/dfwngq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.